E
Edward H. Giannini
Researcher at Cincinnati Children's Hospital Medical Center
Publications - 134
Citations - 14228
Edward H. Giannini is an academic researcher from Cincinnati Children's Hospital Medical Center. The author has contributed to research in topics: Juvenile rheumatoid arthritis & Arthritis. The author has an hindex of 55, co-authored 134 publications receiving 13524 citations. Previous affiliations of Edward H. Giannini include University of Cincinnati Academic Health Center & Boston Children's Hospital.
Papers
More filters
Journal ArticleDOI
Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States
Reva C. Lawrence,Charles G. Helmick,Frank C. Arnett,Richard A. Deyo,David T. Felson,Edward H. Giannini,Stephen P. Heyse,Rosemarie Hirsch,Marc C. Hochberg,Gene G. Hunder,Matthew H. Liang,Stanley R. Pillemer,Virginia D. Steen,Frederick Wolfe +13 more
TL;DR: Given the limitations of the data on which they are based, this report provides the best available prevalence estimates for arthritis and other rheumatic conditions overall, and for selected musculoskeletal disorders, in the US population.
Journal ArticleDOI
Etanercept in Children with Polyarticular Juvenile Rheumatoid Arthritis
Daniel J. Lovell,Edward H. Giannini,Andreas Reiff,Gail Cawkwell,Earl D. Silverman,James J. Nocton,Leonard D. Stein,Abraham Gedalia,Norman T. Ilowite,Carol A. Wallace,James B Whitmore,Barbara K. Finck +11 more
TL;DR: Treatment with etanercept leads to significant improvement in patients with active polyarticular juvenile rheumatoid arthritis and is well tolerated by pediatric patients.
Journal ArticleDOI
Preliminary definition of improvement in juvenile arthritis
Edward H. Giannini,Nicolino Ruperto,Angelo Ravelli,Daniel J. Lovell,David T. Felson,Alberto Martini +5 more
TL;DR: Use of a uniform definition of improvement will help standardize the conduct and reporting of clinical trials, and should help practitioners decide if a child with JA has responded adequately to therapy.
Journal ArticleDOI
Adalimumab with or without Methotrexate in Juvenile Rheumatoid Arthritis
Daniel J. Lovell,Nicolino Ruperto,Steven N. Goodman,Andreas Reiff,Lawrence Jung,Katerina Jarosova,Dana Nemcova,Richard Mouy,Christy Sandborg,John F. Bohnsack,Dirk Elewaut,Ivan Foeldvari,Valeria Gerloni,Jozef Rovensky,Kirsten Minden,Richard K. Vehe,L. Wagner Weiner,Gerd Horneff,Hans Iko Huppertz,Nancy Y. Olson,John R. Medich,Roberto Carcereri-De-Prati,Melissa J. McIlraith,Edward H. Giannini,Alberto Martini +24 more
TL;DR: Adalimumab therapy seems to be an efficacious option for the treatment of children with juvenile rheumatoid arthritis.
Journal ArticleDOI
Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial
Nicolino Ruperto,Daniel J. Lovell,Pierre Quartier,Eliana Paz,Nadina Rubio-Pérez,Clovis A. Silva,Carlos Abud-Mendoza,Ruben Burgos-Vargas,Valeria Gerloni,José Melo-Gomes,Claudia Saad-Magalhães,Flavio Sztajnbok,Claudia Goldenstein-Schainberg,Morton Scheinberg,Immaculada Calvo Penades,Michael Fischbach,Javier Orozco,Philip J. Hashkes,Christine Hom,Lawrence Jung,Loredana Lepore,Sheila Knupp Feitosa de Oliveira,Carol A. Wallace,Leonard H. Sigal,Alan J. Block,A Covucci,Alberto Martini,Edward H. Giannini +27 more
TL;DR: The safety and efficacy of abatacept, a selective T-cell costimulation modulator, in children with juvenile idiopathic arthritis who had failed previous treatments was assessed.